Production (Stage)
Celularity Inc.
CELU
$1.79
$0.042.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 18.13M | 9.30M | 12.11M | 14.68M | 12.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.13M | 9.30M | 12.11M | 14.68M | 12.11M |
| Cost of Revenue | 7.34M | 3.88M | 2.12M | 1.64M | 9.61M |
| Gross Profit | 10.79M | 5.41M | 9.99M | 13.04M | 2.50M |
| SG&A Expenses | 16.06M | 12.65M | 15.91M | 14.03M | 13.07M |
| Depreciation & Amortization | 376.00K | 375.00K | 456.00K | 546.00K | 553.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.61M | 20.82M | 22.29M | 22.06M | 22.96M |
| Operating Income | -9.47M | -11.53M | -10.18M | -7.38M | -10.85M |
| Income Before Tax | -13.29M | -16.10M | -6.49M | -22.01M | 9.56M |
| Income Tax Expenses | -- | -- | -- | -- | 10.00K |
| Earnings from Continuing Operations | -13.29M | -16.10M | -6.49M | -22.01M | 9.55M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.29M | -16.10M | -6.49M | -22.01M | 9.55M |
| EBIT | -9.47M | -11.53M | -10.18M | -7.38M | -10.85M |
| EBITDA | -7.60M | -9.63M | -8.18M | -5.22M | -8.55M |
| EPS Basic | -0.60 | -0.73 | -0.30 | -1.03 | 0.50 |
| Normalized Basic EPS | -0.36 | -0.46 | -0.18 | -0.53 | 0.35 |
| EPS Diluted | -0.60 | -0.73 | -0.30 | -1.03 | 0.50 |
| Normalized Diluted EPS | -0.36 | -0.46 | -0.18 | -0.53 | 0.35 |
| Average Basic Shares Outstanding | 22.29M | 21.98M | 21.85M | 21.44M | 19.19M |
| Average Diluted Shares Outstanding | 22.29M | 21.98M | 21.85M | 21.44M | 19.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |